Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

As India’s Diabetes Market Grows, Eli Lilly Brings In A New Leader

Aug 26 2013

• By Vikas Dandekar

Related Content

Seeking Broad Intervention In India, Eli Lilly Goes To Roots To Check Non-communicable Diseases

Sep 16 2011

Rising Cases Of NCDs Prompts Indian Government To Step Up Healthcare, Screening Programs

Sep 12 2011

Eli Lilly, Boehringer Ingelheim Combine Might To Push Brands As India's Diabetes Market Expands

Oct 04 2011

Eli Lilly Ropes In Lupin For A Big Push For Its Insulin Brands In India

Aug 01 2011

Related Companies

Eli Lilly and Company

Lupin Limited

Novo Nordisk A/S

Sanofi

Boehringer Ingelheim GmbH

Glenmark Pharmaceuticals Limited

Merck & Co., Inc.

Additional Topics

Asia Pacific India Emerging Markets Deals Leadership BioPharmaceutical

More from Focus On Asia

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window